ARTICLE | Company News
Schwarz and Alviva in CNS development
October 12, 2000 7:00 AM UTC
Schwarz (Monheim, Germany) obtained access to a group of compounds from Alviva (Saskatoon, Saskatchewan) to address neurodegenerative diseases such as Parkinson's, Alzheimer's, Huntingdon's and Amyotr...